Patents Assigned to FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA
  • Patent number: 9732091
    Abstract: The present application discloses novel family of Tryptophanol-Derived Oxazoloisoindolinones for use in the treatment of p53 associated conditions, such as cancer. These compounds are p53 activators and may be used in pharmaceutical compositions, alone or in combination with other chemotherapeutic agents.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: August 15, 2017
    Assignees: UNIVERSIDADE DO PORTO, FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA
    Inventors: Lucilia Helena Ataide Saraiva, Maria Manuel Duque Vieira Marques Dos Santos, Nuno Alexandre Lousa Pereira, Clara Isabel Ferreira Pereira, Sara Gomes Moreira, Mariana Valencia Castanheira Ferreira Leao, Angelo Filipe Almeida Monteiro, Joana Oliveira Gama Soares